"10.1371_journal.pone.0021621","plos one","2011-06-24T00:00:00Z","Jarel Gandhi; Siobhan M Cashman; Rajendra Kumar-Singh","Department of Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts, United States of America","Conceived and designed the experiments: JG SMC RK-S. Performed the experiments: JG SMC. Analyzed the data: JG SMC RK-S. Contributed reagents/materials/analysis tools: RK-S. Wrote the paper: SMC RK-S.","Tufts University has applied for a patent describing the use of soluble CD59 to inhibit membrane attack complex deposition in diseases associated with complement. Tufts University may decide on a future date to commercialize such patents through licensing agreements. R.K.-S. is employed by Tufts University and serves as a consultant for (and holds equity in) Hemera Biosciences Inc. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","06","Jarel Gandhi","JG",3,TRUE,3,2,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
